http://purl.org/np/RAmhgfMT81... RAmhgfMT81

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#wasQuotedFrom wasQuotedFrom

https://dailymed.nlm.nih.gov/d...00-e973-4bab-810c-b69f6c8ee4f3 drugInfo.cfm?setid=d6f08000-e973-4bab-810c-b69f6c8ee4f3

Leoni Bücken

2021-04-03T09:43:28.407Z

http://purl.org/np/RAmhgfMT81... RAmhgfMT81

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/ns/prov#value value

Trihexyphenidyl is indicated as an adjunct in the treatment of all forms of parkinsonism (postencephalitic, arteriosclerotic, and idiopathic). It is often useful as adjuvant therapy when treating these forms of parkinsonism with levodopa.

Leoni Bücken

2021-04-03T09:43:28.407Z

http://purl.org/np/RAmhgfMT81... RAmhgfMT81

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://purl.org/np/RAmhgfMT81...#medtherapy medtherapy

http://www.w3.org/ns/prov#wasDerivedFrom wasDerivedFrom

Leoni Bücken

2021-04-03T09:43:28.407Z